Objective: This study examined the association between hospital mortality and five illness-severity scoring systems evaluated at different time points in the intensive care unit (ICU) as well as clinical variables as predictors in critically ill patients supported by extracorporeal membrane oxygenation (ECMO) and acute dialysis. Methods: This multicenter prospective observational study included 104 patients who received ECMO support and acute dialysis from January 2002 to December 2006. Patients' demographic, clinical and laboratory variables were analyzed as predictors of survival. The SAPS 2, APACHE II, SOFA, MODS, and SAPS 3 scores upon ICU admission and at acute dialysis commencement were evaluated to predict the patient's hospital mortality. Results: Hospital mortality for the study group was 76% (79/104). Among the five scoring systems, only SAPS 3 score showed a significant difference between survivors and non-survivors either upon ICU admission ( p = 0.038) or at dialysis commencement ( p = 0.001). SAPS 3 score at dialysis commencement showed the best discrimination ability by using the area under the receiver operating characteristic curve (SOFA, 0.55; SAPS 2, 0.56; MODS, 0.58; APACHE II, 0.59; and SAPS 3, 0.73). Multiple logistic regression analysis indicated that SAPS 3 score at dialysis commencement (OR: 1.070, 95% CI: 1.016-1.216) and IABP usage before ECMO (OR: 4.181, 95% CI: 1.448-12.075) were two independent risk factors for hospital mortality. Conclusions: Among five common ICU scoring systems evaluated at different time points, SAPS 3 at dialysis commencement is the best risk adjustment systems to predict hospital mortality in critically ill patients supported by ECMO and acute dialysis. Furthermore, the SAPS 3 score at dialysis commencement and IABP usage before ECMO are two major independent predictors for hospital mortality in patients supported by ECMO and acute dialysis. #
Introduction
Extracorporeal membrane oxygenation (ECMO) can provide temporary cardiac or respiratory support to critically ill patients. It has been successfully used in patients with cardiopulmonary failure, whether they are neonates, children or adults [1] [2] [3] . The indications for ECMO therapy extended from cardiogenic shock, fulminant myocarditis, severe respiratory failure refractory to conventional ventilation [1] [2] [3] [4] , although its benefits in certain situations, such as ARDS, are still inconclusive [5, 6] . According to the literature, ECMO patients have a high mortality rate around 50-76%. Acute renal failure, as a manifestation of multiple organ failure, is common in critical patients who received ECMO and would further increase the mortality rate [6] [7] [8] [9] . In our previous study, dialysis for acute renal failure was a significant predictor of mortality in ECMO patients, with an odds ratio of up to eight times [7] .
ECMO is an expensive therapy and not all critically ill patients could benefit from it. Issues about when to use it, what has a better outcome, and when to stop it are still controversial. Thus a good risk adjustment model for outcome prediction is an important issue in critical care. Despite the appearance of several specialized scoring systems, the general mortality prediction systems such as Acute Physiology and Chronic Health Evaluation score (APACHE), Simplified Acute Physiology Score (SAPS) and Multiple Organ Dysfunction Score (MODS), Sequential Organ Failure Assessment (SOFA) and their constantly improved successors have become the most popular and widely tested models [10] [11] [12] [13] [14] . However, the capacities of these scores were never evaluated in critical ECMO patients receiving ECMO and acute dialysis. In this study, we examined the association between hospital mortality and five illnessseverity scoring systems evaluated at different time points in the intensive care unit (ICU) as well as clinical variables in critically ill patients supported by ECMO and acute dialysis. We further analyzed if there is any predictor for hospital mortality in patients receiving ECMO support and acute dialysis.
Materials and methods

Study population
The current study was based on an analysis of a database of acute renal failure patients in the surgical ICU of the National Taiwan University Hospital, its three branch hospitals and the database of the National Taiwan University Surgical ICU Acute Renal Failure (NSARF) study group. The database was prospectively collected from all patients admitted to SICU since 2002 who had complication of ARF during their ICU stay.
From January 2002 to December 2006, 346 patients admitted to the surgical ICU received ECMO implantation. One hundred and ninety patients (55%) received ECMO support with acute dialysis. Patients were excluded if they were younger than 18 years (n = 55), and if had received chronic dialysis before ICU admission (n = 3). A total of 104 adult patients (!18 years old), who received ECMO support for more than 24 h and acute dialysis, either simultaneously or sequentially, were recruited in this study. Approval for this study was obtained from the institutional review board of the National Taiwan University Hospital (Taipei, Taiwan, No. 31MD03). Besides, written consent was obtained from the patients or their next of kin.
ECMO device
The ECMO support was performed as described previously [4, 6, 15] . In brief, our ECMO device (Medtronic Inc, Anaheim, CA) consisted of a centrifugal pump and a hollow-fiber microporous membrane oxygenator with an integrated heater. All ECMO circuits had heparin-bound Carmeda bioactive surface.
Intervention of acute dialysis
The indications for acute dialysis included: (1) azotemia (BUN >80 mg/dl and serum creatinine >2 mg/dl) and uremic symptoms, (2) fluid overload refractory to diuretics with central venous pressure >12 mmHg or pulmonary edema with a PaO 2 /FiO 2 <300 mmHg, (3) hyperkalemia (serum potassium >5.5 mmol/l) despite medical treatment, (4) oliguria (urine amount <100 ml/8 h) without the use of diuretics, and (5) severe acidosis (pH <7.2).
Post-ECMO continuous arteriovenous hemofiltration (CAVH) was performed with a hemofilter (FH66, Gambro, Hechingen, Germany) and connected to pre-and postoxygenator circuits of the ECMO with a blood flow of around 350 ml/min, depending on the intervening pressure gradient, and a hemofiltration flow of 35 ml/kg/h controlled by a pump. Replacement fluid was bicarbonate-buffered and was administered post-dilution at a dynamically adjusted rate to achieve the desired fluid therapy. Default composition of the replacement fluid was Na + 142 mEq/l, bicarbonate 33 mEq/l, Mg 2+ 1.4 mEq/l, and Ca 2+ 2.6 mEq/l.
Data collection and definition
Data including age, sex, comorbidity, type of surgery, indication for ECMO, indication for acute dialysis, outcome, physiological data, and laboratory data upon admission to ICU and at the time of dialysis commencement were collected. Shock was defined as systolic blood pressure <90 mmHg with evidence of tissue hypoperfusion (e.g., decreased urine output, altered mental status) or the need for high dose inotropic agents. Inotropic equivalents (IE, mg/kg/min = dopamine + dobutamine + 100 Â epinephrine + 100 Â norepinephrine + 100 Â isoisoprotenolol + 15 Â milrinone) were used to evaluate the catecholamine dose [16] .
The SAPS 2, APACHE II, SOFA, MODS, SAPS 3 scores at ICU admission were calculated according to the previous publications [10] [11] [12] [13] [14] . We also used the physiologic parameters observed at the time of dialysis commencement to calculate pre-dialysis scores. The primary outcome was hospital mortality.
Statistical analyses
Statistical analyses were performed using the SAS/STAT W software, Version 9.1.3 (SAS Institute Inc., Cary, NC, USA). Continuous variables were described by mean AE standard deviation (SD). Continuous variables between groups were compared using Student's two-tailed t test or the MannWhitney U test if not normally distributed. The chi-square test was applied for categorical data. All potential predictors were evaluated in univariate analysis and in multivariate analysis by multiple logistic regression with a stepwise forward method in order to obtain risk factors of hospital mortality. The two-tailed p value of <0.05 was considered to be statistically significant. Basic model-fitting techniques for regression analysis, including (1) variable selection, (2) goodness-of-fit (GOF) assessment, and (3) regression diagnostics were applied to assure the quality of analysis results. Discrimination for hospital mortality was determined by means of the area under the receiver operating characteristic (ROC) curve, comparing between all scores. We performed goodness-of-fit test using the Hosmer-Lemeshow statistics and plotted observed and predicted mortality in each quintile of risk for assessing the agreement between the actual and predicted death rates. The predicted mortality was plotted according to specific customized equations the SAPS 3 designs for the different geographic regions. We used conditional effect plots, which predicted values of Y against one X variable, with the other X variables held in constant.
Results
Patient characteristics
Between January 2002 and December 2006, 104 patients receiving ECMO support and acute dialysis at ICU were enrolled in this study. Patients' median age was 51 years (range 19-84); 60 were male (57.7%) and 44 were female (42.3%). Hospital mortality for the entire group was 76% (79/ 104) ( Table 1 ).
The indications of ECMO included post-cardiotomy cardiogenic shock (n = 45), dilated cardiomyopathy (n = 27), heart graft dysfunction (n = 6), fulminant myocarditis (n = 5), acute respiratory distress syndrome (n = 5), lung graft dysfunction (n = 5), and others (n = 10). Cardiogenic shock was the most common reason for ECMO support. Of 62 patients (60%) who received an operation, 46 patients (74.2%) had emergent operations. The indications for acute dialysis were as follows: oliguria and anuria (n = 85, 81.7%), fluid overload (n = 41, 39.4%), azotemia and uremic symptom (n = 40, 38.5%), severe rhabdomyolysis (n = 7, 6.7%), acid base imbalance (n = 4, 3.8%) and electrolyte imbalance (n = 1, 1%). Table 1 compares characteristics of survivors and nonsurvivors. Most patients (91/104, 87.5%) suffered from shock before receiving ECMO. More non-survivors had comorbidity with diabetes (22% vs 7%, p = 0.034) and implantation of an intra-aortic balloon pump (IABP) before ECMO (60.7% vs 24%, p = 0.001) than survivors. Non-survivors had older age, higher SAPS 3 score at dialysis commencement, decreased Glasgow coma scale (GCS) at dialysis commencement, and increased serum creatinine and total bilirubin.
Comparison between survivors and non-survivors
Comparison of scores upon ICU admission and at dialysis commencement
The mean scores of SAPS 2, APACHE II, SOFA, MODS, SAPS 3 of survivors and non-survivors upon ICU admission and at the time of dialysis commencement are showed in Table 2 . Among the different scoring systems, SAPS 3 scores, upon ICU admission ( p = 0.038) and at dialysis commencement ( p = 0.001), and APACHE II scores at dialysis commencement ( p = 0.024) had significant differences between the survivors and non-survivors. Areas under the ROC curves for these scoring systems at dialysis commencement were: SOFA, 0.55; SAPS 2, 0.56; MODS, 0.58; APACHE II, 0.59; and SAPS, 0.73 (Table 3) . Thus, SAPS 3 score at dialysis commencement has the best discriminatory power ( p < 0.05) among these scores either at ICU admission or at dialysis commencement (Fig. 1) . Analysis of the goodness-of-fit by Hosmer-Lemeshow statistics demonstrated good calibration for SAPS 3 at dialysis commencement ( p = 0.71). Fig. 2 shows the observed and predicted mortalities in quintiles of risk for SAPS 3. The predicted mortality was plotted according to specific customized equations log odds of hospital mortality = À64.5990 60 + ln (SAPS 3 score at dialysis commencement + 71.0599060) Â 13.2322, which is most approximated to observed mortality, after comparing to five customized equations the SAPS 3 scores designs for different geographic regions for the prediction of hospital mortality.
Multiple logistic regression model for predictors of hospital mortality
The multivariate analyses by fitting multiple logistic regression models using the stepwise variable selection method showed that SAPS 3 score at dialysis commencement (OR: 1.070, 95% CI: 1.016-1.216) and usage of IABP (OR: 4.181, 95% CI: 1.448-12.075) were two major independent risk factors of hospital mortality (Table 4) . Since multivariable analysis showed IABP usage before ECMO was a strong predictor with odd ratio 4.18, we plotted hospital mortality of patients with IABP usage or not in separate lines. Fig. 3 shows the conditional effect plot of SAPS 3 at dialysis commencement; at a SAPS 3 score of 60 points, the estimated hospital mortality was around 80% in these patients with IABP usage and 40% in those without IABP usage. New model with SAPS 3 score plus with or without IABP usage has 79% concordant rate. Since these new regression models fitted the observed data well (GOF test p > 0.05), they could be used for prediction in clinical practice. SAPS 3 score at dialysis commencement with IABP usage together can stratify these ECMO patients who has much higher risk of hospital mortality.
Discussion
Severe acute renal failure requiring acute dialysis is common in critical patients who receive ECMO and is an important risk factor for mortality in these patients. In this study, the hospital mortality rate in patients who received ECMO with acute dialysis was 76% (79/104) and 30-day mortality rate was 64% (67/104). Meanwhile, the hospital mortality rate in patients who received ECMO without acute dialysis at the same time (between 2002 and 2006) in our hospital was 56% (86/154, unpublished data).
With the extreme high cost of ECMO support and uncertain benefits to all critical patients, risk stratification to predict patients who have best chance of survival is crucial in critical care. Therefore, several studies have tried to identify risk factors to predict the mortality. There have been some mortality predictors identified, including cardiac arrest before ECMO, serum lactate level, oxygenation index, and multiple organ failure [17] [18] [19] . However, these predictors identified are inconsistent among the previous studies. For instance, in a retrospective study of 49 neonates with severe hypoxemia requiring ECMO, the authors found that plasma lactate level higher than 25 mM was associated with higher mortality [15] . In adults, hyperlactatemia has been proven to be correlated well with mortality in ICU patients. In our previous study, we also found lactate >3 mmol/l as a risk factor [20] . However, in this study, the serum lactate level was much higher than 3 mmol/l in most patients and was not associated with mortality. Although the mean lactate level is higher in non-survivors than survivors, there was no statistically significant difference. The negative finding may be due to selection bias; patients in the present study were selected from a very critically ill subgroup who needed both ECMO and dialysis with plasma lactate levels higher than previous studies.
In our previous study which enrolled 78 patients supported with ECMO for cardiac shock, five risk factors were statistically significant according to the multivariate analysis: systemic infection, lung dysfunction, renal dysfunction, lactate >3 mmol/l, and creatine kinase (CK) >10,000 U/l. Based on these five variables, we attempted to develop a Risk Factor-Scaling Score (RFSS) to select patients who, supported by ECMO, were suitable for heart transplantation or ventricular assist device [16] . Disappointingly, neither plasma lactate nor plasma CK level can predict hospital mortality in the present investigation. Thus RFSS is invalid in patients who received ECMO and acute dialysis.
So, in this study, we examined five score models, SAPS 2, APACHE II, SOFA, MODS, SAPS 3, to predict hospital mortality in patients who received ECMO and acute dialysis. The latest evolution in this field is SAPS 3 which is the first 'global' model using a dataset acquired from 307 ICUs from all over the world [21] and showed the best performance in our study. SAPS means simplified APACHE Acute Physiology Score (APS). The SAPS 2, including 17 variables, was first published in 1994, while SAPS 3 was published in 2005. SAPS 3 includes 20 variables [13] . The original SAPS score requires data collected during the first 24 h after ICU admission. However, in our study, when the data collected at the time of dialysis Fig. 3 . Conditional effect plot of SAPS 3 score at dialysis commencement for patients using and not using IABP before ECMO. Probability of hospital death is estimated for each value of SAPS 3 score at dialysis commencement, adjusted by IABP usage before ECMO or not. commencement were applied, instead of the data within the first 24 h after ICU admission, the performance of these five scoring systems became better. It has been observed in other scoring systems that sequential/serial evaluation of scores provides better outcome prediction [22] . For example, APACHE II scores at 48 h correctly shows predicted outcome in 88% of acute pancreatitis patients than APACHE II scores at the time of admission [23] . In another multicenter cohort study, the most important factor determining daily risk of hospital death during the initial 7 days of ICU care was the current day's APACHE III score [24] . SAPS 3 score has been recently used for patients with cancer in need of intensive care, and it showed an excellent discrimination (AUROC !0.8) [25] . Furthermore, the observed mortality was closer to the predicted mortality. Although the performance of SAPS 3 in our study was not as good as that in cancer patients, it predicted mortality better than SAPS 2, APACHE II, SOFA, and MODS scoring systems. Compared to the other four scoring systems, SAPS 3 includes more variables: use of vasoactive drugs, intra-hospital location, length of stay in the hospital before ICU admission, reason(s) for ICU admission, planned/ unplanned ICU admission, surgical status at ICU admission, anatomical site of surgery, and presence of infection at ICU admission [13] . It may be the reason why the other four scores, including fewer variables, have less power in predicting hospital mortality in our study. In addition, the predicted mortality was closer to the observed mortality in high SAPS 3 score range. The reason that SAPS 3 underestimated the mortality rate in the low score range maybe because parameters such as systemic blood pressure under ECMO is pseudo-normalized, which can be observed in the paradoxical data: most enrolled patients (91/104, 87.5%) were in shock status before ECMO, however, mean systolic blood pressure was 102 mmHg under ECMO support at initiation of dialysis. Combining IABP usage or not before ECMO and SAPS 3 score, we can better stratify these ECMO patients receiving dialysis.
There are some limitations in this study. First, SAPS 3 has not been validated in the Asian area or for subgroups such as patients who received ECMO. The original SAPS 3 has developed specific customized equations across the different geographic regions to provide more precise estimation of the probability of death [13] . However, no equation has been developed in Asian countries in the original SAPS 3. Second, many risk adjustment systems were found to lack calibration over several subgroups of patients, often accompanied by an underestimation of mortality in lowrisk patients and an overestimation in high risk patients [12] . It did observe, in the present study, that SAPS 3 may underestimate mortality in low scores level. However, we found the SAPS 3 score at dialysis commencement can predict hospital mortality in ECMO patients who received acute dialysis. Furthermore, after adjusting for IABP usage or not before ECMO, a major independent predictor of hospital death, we found that SAPS 3 score at dialysis commencement did stratify high-risk patients in this subgroup of patients. The findings in our study might allow clinicians to access different therapeutic approaches, guide individual patient treatment, evaluate new treatments in clinical trials, assess resource allocation, and explain patient severity to family members.
